MS Speaks
Multiple Sclerosis => TREATMENTS => BRIUMVI (ublituximab) => Topic started by: agate on April 17, 2026, 08:58:06 pm
-
From Zacks.com (April 16, 2026)--"TGTX completes enrollment in Phase III study on subcutaneous Briumvi":
https://www.zacks.com/stock/news/2901461/tgtx-completes-enrollment-in-phase-iii-study-on-subcutaneous-briumvi